Literature DB >> 10449305

Atorvastatin for protease inhibitor-related hyperlipidaemia.

J Murillas, T Martín, A Ramos, J L Portero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10449305     DOI： 10.1097/00002030-199907300-00030

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients.

Authors:  Sudershan Singh; James H Willig; Michael J Mugavero; Paul K Crane; Robert D Harrington; Robert H Knopp; Bradley W Kosel; Michael S Saag; Mari M Kitahata; Heidi M Crane
Journal:  Clin Infect Dis       Date:  2010-12-28       Impact factor: 9.079

Review 2.  Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.

Authors:  H S Malhotra; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.

Authors:  P H Hsyu; M D Schultz-Smith; J H Lillibridge; R H Lewis; B M Kerr
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 4.  Evaluation and management of dyslipidemia in patients with HIV infection.

Authors:  Michael L Green
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

Review 5.  Evidence-based review of statin use in patients with HIV on antiretroviral therapy.

Authors:  Daniel B Chastain; Kayla R Stover; Daniel M Riche
Journal:  J Clin Transl Endocrinol       Date:  2017-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.